[Whitepaper] Prescription Drug Pricing: How Lack of Transparency Reduces Market Access, Utilization, and Adherence
It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers.
Determining to what extent pricing drives adherence versus abandonment has become that much more important. As out-of-pocket spending increases, consumers are less likely to fill their prescriptions. Although that sounds simple enough to solve, the reality is that the pharmacy ecosystem is anything but simple.
Through open and transparent interactions, the industry can offer innovative solutions and strategic programs that allow brands to offer patients real-time benefit check, savings, and therapy support. Download this whitepaper now to learn more about prescription drug price transparency and its role in creating affordability, accessibility, and accountability.